Urocanic acid improves transfection efficiency of polyphosphazene with primary amino groups for gene delivery

Bioconjugate Chemistry

Volumn 21, Issue 3, 2010, Pages 419-426

  Yang, Yongxin ^a   Zhang, Zhiwen ^a   Chen, Lingli ^a   Gu, Wangwen ^a   Li, Yaping ^a,b  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b NONE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; EFFICIENCY; GENE EXPRESSION; LANTHANUM COMPOUNDS; MOLECULAR BIOLOGY; NANOPARTICLES;

CATIONICS; COMPLEX NANOPARTICLES; DNA COMPLEX; GENE DELIVERY; PHOSPHAZENES; POLYPHOSPHAZENES; PRIMARY AMINO GROUPS; TRANSFECTION ACTIVITY; TRANSFECTION EFFICIENCY; UROCANIC ACID;

GENE TRANSFER;

ACETIC ACID; BAFILOMYCIN A1; DNA; ENHANCED GREEN FLUORESCENT PROTEIN; NANOPARTICLE; POLYETHYLENEIMINE; POLYETHYLENEIMINE DNA COMPLEX NANOPARTICLE; POLYMER; POLY[2 (2 AMINOETHOXY)ETHOXY]PHOSPHAZENE; POLY[2 (2 AMINOETHOXY)ETHOXY]PHOSPHAZENE 25 DNA COMPLEX NANOPARTICLE; POLY[2 (2 AMINOETHOXY)ETHOXY]PHOSPHAZENE 7 DNA COMPLEX NANOPARTICLE; UNCLASSIFIED DRUG; UROCANIC ACID; AMINE; ETHYLAMINE; ORGANOPHOSPHORUS COMPOUND; POLY(2-(2-AMINOETHOXY)ETHOXY)PHOSPHAZENE;

ACIDIFICATION; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; DRUG UPTAKE; ENDOSOME; HELA CELL; NONVIRAL GENE DELIVERY SYSTEM; SYNTHESIS; ANIMAL; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; DOSE RESPONSE; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; HELA CELL LINE; HETEROZYGOTE; HUMAN; PARTICLE SIZE; PLASMID; PROCEDURES; STRUCTURE ACTIVITY RELATION; SURFACE PROPERTY;

AMINES; ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; COS CELLS; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHYLAMINES; HELA CELLS; HETEROZYGOTE; HUMANS; MOLECULAR STRUCTURE; NANOPARTICLES; ORGANOPHOSPHORUS COMPOUNDS; PARTICLE SIZE; PLASMIDS; POLYMERS; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES; TRANSFECTION; UROCANIC ACID;

EID: 77949821747     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc900267g     Document Type: Article

References (27)

1. Wightman, L., Kircheis, R., Rössler, V., Carotta, S., Ruzicka, R., Kursa, M., and Wagner, E. (2001) Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J. Gene. Med. 3, 362-372.
2. Koping-Hoggard, M., Mel'nikovas, Y. S., Varum, K. M., Lindman, B., and Artursson, P. (2003) Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo. J. Gene. Med. 5, 130-141.
3. Ahn, C. H., Chae, S. Y., Bae, Y. H., and Kim, S. W. (2004) Synthesis of biodegradable multi-block copolymers of poly(Llysine) and poly(ethylene glycol) as a non-viral gene carrier. J. Controlled Release 97, 567-574.
4. Vincent, L., Varet, J., Pille, J. Y., Bompais, H., Opolon, P., Maksimenko, A., Malvy, C., Mirshahi, M., Lu, H., Vannier, J. P., Soria, C., and Li, H. (2003) Efficacy of dendrimer-mediated Angiostatin andTIMP-2 gene delivery on inhibition of tumor growth and angiogenesis:in vitro and in vivo studies. Int. J. Cancer 105, 419-429.
5. Ahn, H. H., Lee, J. H., Kim, K., Lee, J. Y., Kim, M. S., Khang, G., Lee, I. W., and Lee, H. B. (2008) Polyethyleneimine-mediated gene delivery into human adipose derived stem cells. Biomaterials 29, 2415-2422.
6. Lavertu, M., Méthot, S., Tran-Khanh, N., and Buschmann, M. D. (2006) High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials 27, 4815-4824.
7. Nimesh, S., Kumar, R., and Chandra, R. (2006) Novel polyallylamine- dextran sulfate-DNA nanoplexes:Highly efficient non-viral vector for gene delivery. Int. J. Pharm. 320, 143-149.
8. Zhang, J. X., Li, X. J., Qiu, L. Y., Li, X. H., Yan, M. Q., Jin, Y., and Zhu, K. J. (2006) Indomethacin-loaded polymeric nanocarriers based on amphiphilic polyphosphazenes with poly (N-isopropylacrylamide) and ethyl tryptophan as side groups: Preparation, in vitro and in vivo evaluation. J. Controlled Release 116, 322-329.
9. Caliceti, P., Veronese, F. M., and Lora, S. (2000) Polyphosphazene microspheres for insulin delivery. Int. J. Pharm. 211, 57-65.
10. Luten, J., van Steenis, J. H., van Someren, R., Kemmink, J., Schuurmans-Nieuwenbroek, N. M. E., Koning, G. A., Crommelin, D. J. A., van Nostrum, C. F., and Hennink, W. E. (2003) Water-soluble biodegradable cationic polyphosphazenes for gene delivery. J. Controlled Release 89, 483-497.
11. de Wolf, H. K., Luten, J., Snel, C. J., Oussoren, C., Hennink, W. E., and Storm, G. (2005) J. Controlled Release 109, 275-287.
12. Luten, J., van Steenbergen, M. J., Lok, M. C., de Graaff, A. M., van Nostrum, C. F., Talsma, H., and Hennink, W. E. (2008) In vivo tumor transfection mediated by polyplexes based on biodegradable poly(DMAEA)-phosphazene. Eur. J. Pharm. Sci. 33, 241-251.
13. Yang, Y. X., Xu, Z. H., Jiang, J. G., Gao, Y., Gu, W. W., Chen, L. L., Tang, X. Z., and Li, Y. P. (2008) Poly(imidazole/ DMAEA)phosphazene/DNA self-assembled nanoparticles for gene delivery: Synthesis and in vitro transfection. J. Controlled Release 127, 273-279.̌
14. Remy-Kristensen, A., Clamme, J. P., Vuilleumier, C., Kuhry, J. G., and Mely, Y. (2001) Role of endocytosis in the transfection of L929 fibroblasts by polyethylenimine/DNA complexes. Biochim. Biophys. Acta 1514, 21-32.
15. Merdan, T., Kunath, K., Fischer, D., Kopeček, J., and Kissel, T. (2002) Intracellular processing of poly(ethylene imine)/ ribozyme complexes can be observed in living cells by using confocal laser scanning microscopy and inhibitor experiments. Pharm. Res. 19, 140-146.
16. Allcock, H. R., and Chang, J. Y. (1991) Poly(organophosphazenes) with oligopeptides as side groups:prospective biomaterials. Macromolecules 24, 993-999.
17. Tseng, W. C., Fang, T. Y., Su, L. Y., and Tang, C. H. (2005) Dependence of transgene expression and the relative buffering capacity of dextran-grafted polyethylenimine. Mol. Pharmaceutics 2, 224-232.
18. Huth, U., Schubert, R., and Peschka-Suss, R. (2006) Investigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bio-imaging. J. Controlled Release 110, 490-504.
19. Zhang, P. C., Wang, J., Leong, K. W., and Mao, H. Q. (2005) Ternary complexes comprising polyphosphoramidate gene carriers with different types of charge groups improve transfection efficiency. Biomacromolecules 6, 54-60.
20. van de Wetering, P., Moret, E. E., Schuurmans-Nieuwenbroek, N. M., van Steenbergen, M. J., and Hennink, W. E. (1999) Structure-Activity relationships of water-soluble cationic methacrylate/ methacrylamide polymers for nonviral gene delivery. Bioconjugate Chem. 10, 589-597.
21. Thomas, M., and Klibanov, A. M. (2002) Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 99, 14640-14645.
22. Reschel, T., Konak, C., Oupicky, D., Seymour, L. W., and Ulbrich, K. (2002) Physical properties and in vitro transfection efficiency of gene delivery vectors based on complexes of DNA with synthetic polycations. J. Controlled Release 81, 201-217.
23. Wang, J., Zhang, P. C., Lu, H. F., Ma, N., Wang, S., Mao, H. Q., and Leong, K. W. (2002) New polyphosphoramidate with a spermidine side chain as a gene carrier. J. Controlled Release 83, 157-168.
24. Wolfert, M. A., Dash, P. R., Nazarova, O., Oupicky, D., Seymour, L. W., Smart, S., Strohalm, J., and Ulbrich, K. (1999) Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA. Bioconjugate Chem. 10, 993-1004.
25. Singh, R. S., Goncalves, C., Sandrin, P., Pichon, C., Midoux, P., and Chaudhuri, A. (2004) On the gene delivery efficacies of pH-sensitive cationic lipids via endosomal protonation: A chemical biology investigation. Chem. Biol. 11, 713-723.
26. Cho, Y. W., Kim, J. D., and Park, K. (2003) Polycation gene delivery systems: escape from endosomes to cytosol. J. Pharm. Pharmacol. 55, 721-734.
27. Lechardeur, D., Verkman, A. S., and Lukacs, G. L. (2005) Intracellular routing of plasmid DNA during non-viral gene transfer. Adv. Drug Delivery Rev. 57, 755-767.